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Abstract
Background It is unclear whether plastic or metal stents are
more suitable for preoperative biliary decompression in pan-
creatic cancer. The objective of this study was to compare the
rate of endoscopic reinterventions in patients with pancreatic
cancer undergoing plastic or self-expandable metal stent
(SEMS) placements for preoperative biliary decompression.
Methods This was a retrospective study of all patients
with obstructive jaundice secondary to pancreatic head
cancer who underwent their index endoscopic retrograde
cholangiopancreatography (ERCP) and all follow-up bili-
ary stent placements at our center before undergoing pan-
creaticoduodenectomy. Plastic or SEMS were placed at
ERCP for biliary decompression. The main outcome
measure was to compare the rate of endoscopic reinter-
ventions between the plastic and SEMS cohorts.
Results 29 patients who underwent pancreaticoduodenec-
tomy had preoperative biliary stent placement (18 plastic, 11
SEMS) at our center. Whereas none of the 11 patients who
underwent SEMS placement had stent dysfunction, 7 of 18
(39%) patients with plastic stents required endoscopic rein-
tervention before surgery (P = 0.02). Reinterventions were
due to cholangitis (n = 1) or persistent elevation in serum
bilirubin levels (n = 6). Two patients with SEMS underwent
EUS-guided fine-needle aspiration after ERCP, which yielded
a positive diagnosis of cancer in all cases; SEMS did not
impair visualization of the tumor mass at EUS. Pancreatico-
duodenectomy was undertaken successfully in all 29 patients
and the presence of a SEMS did not interfere with biliary
anastomosis. On univariate logistic regression, only SEMS
placement was associated with less need for endoscopic re-
intervention (P = 0.02).
Conclusions SEMS are superior to plastic stents for
preoperative biliary decompression in pancreatic cancer.
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Pancreatic cancer is the fourth leading cause of cancer-
related deaths in the United States. Cancer of the head of
the pancreas causes biliary obstruction with curative option
being pancreaticoduodenectomy (Whipple’s procedure).
Preoperative endoscopic retrograde cholangiopancreatog-
raphy (ERCP) is usually undertaken in patients with
resectable disease to relieve cholestasis from biliary
obstruction, which is thought to impair immune response,
clotting, and other functions that impact intraoperative and
postoperative outcomes [1–3]. Despite conflicting data
pertaining to preoperative biliary drainage, ERCP with
biliary stenting has become standard practice in patients
with pancreatic head cancer [4–6]. In a recent, multicenter,
randomized trial, patients who underwent preoperative
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biliary drainage had a 74% rate of complications compared
with 39% for those who directly underwent surgery [7]. All
patients in this trial underwent placement of plastic stents.
In ERCP, self-expandable metal stent (SEMS) are being
increasingly placed for palliation of malignant obstructive
jaundice. Compared with plastic stents, SEMS are of large
caliber and have demonstrated longer patency in random-
ized trials [8]. Even in patients with resectable disease,
short SEMS when placed below the level of transection do
not impair technical outcomes at surgery and can be safely
removed along with the surgical specimen [9].
This retrospective study was designed to compare the
rates of endoscopic reintervention in patients with pan-
creatic cancer who underwent SEMS or plastic stent
placement for preoperative biliary decompression.
Materials and methods
The surgical and ERCP databases were queried for all
patients with pancreatic cancer who underwent preopera-
tive endoscopic biliary decompression at the University of
Alabama at Birmingham from January 2006 to December
2009. The ERCP database comprises 72 prospectively
collected variables, which include patient demographics,
laboratory indices and investigations, previous endoscopic
interventions, procedural details, and complications. The
surgical database comprises technical outcomes and com-
plications pertaining to pancreaticoduodenectomy.
Included in the study were all patients (aged[19 year) with
pancreatic head cancer who underwent their index ERCP and
all follow-up biliary stent placements at our center before
undergoing pancreaticoduodenectomy. Excluded were patients
with distant metastasis who underwent palliative surgery,
biliary intervention (percutaneous biliary drainage catheter or
ERCP) performed at outside hospitals for presenting com-
plaints, tumor-related gastric outlet obstruction, cholangitis at
clinical presentation, and those with postsurgical anatomy.
All ERCPs were performed by two attending endosco-
pists (CMW, SV) under conscious sedation using a com-
bination of intravenous midazolam, meperidine, and
ketamine. At ERCP, plastic (10-Fr; length 7–9 cm; Wil-
son-Cook Medical Corporation, Winston-Salem, NC) or
SEMS (10 mm; length, 6 cm; Boston Scientific Corpora-
tion, Nattick, MA) were placed for biliary decompression.
None of the study patients received prophylactic antibiotics
or required reversal medications for coagulation disorders.
Statistical analysis
Patients who underwent plastic and SEMS were compared
for their serum bilirubin levels, tumor size, stricture length,
time between stent placement and surgery, and length of
stay in the hospital after surgery. Continuous variables
have been reported as means (standard deviations) and
medians (IQR) and compared by a two-sample t test or the
Wilcoxon rank-sum test. Categorical variables have been
reported in terms of their frequencies and the two propor-
tions were compared by using the Fisher’s exact test.
A Fisher’s exact test was performed to determine whe-
ther having an endoscopic reintervention is associated with
the type of stent deployed. Similarly, a Fisher’s exact test
was deemed appropriate for assessing whether having an
endoscopic reintervention was associated with the cate-
gorical predictors of interest. Univariate logistic regression
was performed to assess whether the other predictors
(continuous variables) of interest increased or decreased
the odds of having an endoscopic reintervention. Crude
odds ratios and their corresponding 95% confidence inter-
vals (CIs) were calculated for the same. The SAS statistical
software was used for these analyses, and the P values were
reported for a two-sided test. Type I error was set at the
0.05 level of significance.
Evaluation of outcomes
The primary outcome was to compare the rate of endo-
scopic reintervention between patients who underwent
plastic or SEMS placement for preoperative biliary
decompression. Reintervention was defined as the need for
stent exchange when patients developed postprocedural
cholangitis or had persistent hyperbilirubinemia (\50%
decline in serum bilirubin levels after initial stent
placement).
Results
29 (men 55%, Caucasians 59%) of 270 patients (11%) who
underwent pancreaticoduodenectomy had their index
ERCP performed at our institution and constitute the study
cohort. 98 patients who had biliary interventions performed
at outside hospitals and underwent pancreaticoduodenec-
tomy at our institution were excluded. 18 patients (62%)
underwent plastic and 11 (38%) underwent SEMS place-
ments. There was no difference in patient demographics
between both cohorts. The mean age of the patients was
55 year [standard deviation (SD) = 10.8] and 62 year
(SD = 14.2) between patients who underwent metal and
plastic stents, respectively. Four of 11 (37%) and 9 of 18
(50%) patients who underwent metal and plastic stent
placements, respectively, were women. Except for post-
surgical length of stay in the hospital, there was no dif-
ference in serum bilirubin levels, size of the pancreatic
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mass (largest dimension on computed tomogram [CT]),
length of biliary stricture at ERCP, and median duration
between stent placement until surgery between patients
who underwent plastic or SEMS placements (Table 1).
Both endoscopists had a lifetime experience of more than
3,000 ERCP procedures and performed 58% (SV) and 42%
(CMW) of all subjects recruited to this study without dif-
ference between both cohorts.
Whereas all 11 patients who underwent SEMS placement
had successful resolution of jaundice and did not require
reintervention, 7 of 18 patients (39%) who underwent plastic
stent placement underwent a repeat ERCP for stent
exchange. One of seven patients developed cholangitis and
six had persistent elevation in serum bilirubin levels. The
patient who developed cholangitis required hospitalization
for 4 days. Three other patients with persistent hyperbili-
rubinemia had severe pruritus, which required inpatient
hospitalization (median stay, 2 days) for repeat ERCP.
At repeat ERCP, the plastic stents were replaced suc-
cessfully (with 10-Fr plastic stents) and the bilirubin levels
declined in all patients. No patient in either cohort devel-
oped other ERCP-related complications, such as pancrea-
titis or perforation. After stenting, two patients in the SEMS
cohort and one in the plastic stent cohort underwent EUS-
guided fine-needle aspiration (FNA), which was diagnostic
of cancer in all three patients. The presence of a SEMS did
not impact visualization or tissue yield at EUS-guided FNA.
During the study period, none of the patients who had their
index ERCP and subsequent pancreaticoduodenectomy at
our institution had any other biliary interventions performed
at outside hospitals.
At surgery, there was no technical difficulty in removing
the SEMS in any patient. The fully covered metal stent
could be removed without any resistance due to the pres-
ence of a smooth coating, and the partially covered metal
stent required minimal force to be retrieved from the bile
duct (Video 1). Also, there was no difference in the rate of
postoperative complications between patients who under-
went SEMS or plastic stent placements. Two of 11 (18%)
patients who underwent SEMS placement developed post-
surgical complications (surgical wound infection managed
conservatively in 1 and required debridement in the other)
compared with 4 of 18 (22%) patients (postsurgical bleed-
ing in 2, which was managed conservatively in 1 and
resulted in death in a Jehovah’s witness who refused
transfusion, wound infection managed by debridement in 1,
and death due to cardiopulmonary arrest in another) who
underwent plastic stent placement (P = 1.0).
When factors associated with endoscopic reintervention
were analyzed (Table 2), plastic stent placement was
associated with significant increase in the rates of endo-
scopic reintervention (P = 0.026). None of the other
variables were found to increase or decrease significantly
the odds of having a reintervention and hence a multivar-
iable analysis was not performed. Also, because none of
the patients who underwent SEMS placements required
reintervention, it was not possible to compute crude or
adjusted odds ratios.
Table 1 Comparison of the clinical characteristics of the plastic and metal stent cohorts
Variable Plastic stent (n = 18) Metal stent (n = 11) P value
Median (IQR) time between stenting and surgery (days) 24 (10–30) 17 (12–33) 0.685*
Mean (SD) serum bilirubin levels (mg/dl) 12.28 (6.36) 11 (8.77) 0.653**
Mean (SD) tumor size on CT (mm) 29 (8.31) 24.73 (6.68) 0.161**
Mean (SD) stricture length 31.61 (11.45) 30.91 (5.82) 0.829**
Median (IQR) length of stay after surgery (days) 9 (8–12) 7 (7–8) 0.015*
* Unpaired two sample t test; ** Wilcoxon rank-sum test (SD)
SD standard deviation; IQR interquartile range
Table 2 Univariate analysis for
evaluating factors associated
with endoscopic reintervention
* P values calculated using
Fisher’s exact test; CI
confidence interval
Variable Odds ratio 95% CI P value
Time between stent placement and surgery 1 (0.991, 1.011) 0.83
Length of stay after surgery 1.14 (0.868, 1.485) 0.353
Serum bilirubin levels 1.01 (0.892, 1.133) 0.925
Tumor size on CT 1.05 (0.941, 1.177) 0.367
Stricture length at ERCP 1.08 (0.973, 1.19) 0.152
Postoperative complications 0.77 (0.11, 5.16) 1
Stent type (plastic vs. metal) – – 0.026*
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Discussion
In this study, patients who underwent SEMS placements
required no endoscopic reintervention before undergoing
pancreaticoduodenectomy. On the contrary, nearly 40% of
patients who underwent plastic stent placement required a
stent exchange due to development of cholangitis or per-
sistent hyperbilirubinemia.
Plastic biliary stents occlude at a considerably higher rate
and earlier than SEMS, which have a diameter that is 3 times
that of plastic stents. Therefore, most major pancreaticobiliary
centers no longer place plastic stents for good functional
patients with inoperable disease. Of late, a new strategy is
evolving where short-length (4–6 cm) SEMS are being placed
in patients who undergo preoperative ERCP [10]. If resectable
disease is confirmed at surgery, the stent is removed with the
surgical specimen [9]. If the disease is deemed inoperable at
surgery, the patient’s jaundice being already palliated does not
require a major biliary diversion surgery [9, 10]. Also, fully
covered and removable SEMS are currently available and
their use may have additional implications for patients with
resectable pancreatic cancer [11]. Although the impact of
SEMS on tissue procurement is unknown, in this study, the
presence of a metal stent in the bile duct did not obscure tumor
imaging or diminish tissue yield at EUS. Although we
observed no difference in the rates of postoperative compli-
cations between both cohorts, a small sample size could have
precluded meaningful assessment of this outcome.
In a recent randomized trial that compared preoperative
biliary drainage with surgery alone for patients with pancre-
atic cancer, cholangitis related to stent dysfunction developed
in 26% of patients and another one-third of patients underwent
palliative biliary bypass surgery [7]. Also, 30% of patients
required a stent exchange before surgery. These stent-related
complications and the need for endoscopic reintervention
could have been potentially avoided if SEMS were deployed
instead of plastic stents. Also, preoperative adjuvant chemo-
radiation is being administered more often to patients with
cancer of the pancreatic head, thereby further delaying surgery
[12]. SEMS have been shown to provide adequate and durable
biliary decompression in these patients [13].
Limitations of this study include its retrospective design
and the small numbers of enrolled subjects. Nevertheless,
the findings are significant given the careful selection of
subjects who did not have prior endoscopic interventions
and all procedures were performed at one center by dedi-
cated endoscopists and one surgeon. Randomized trials are
in progress to compare the plastic and SEMS for preop-
erative biliary decompression in pancreatic cancer.
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